Nyaman tanpa iklan. Langganan BisnisPro

Kimia farma eyes IDR3.2 trillion revenue

JAKARTA: Indonesias pharmaceutical company, PT Kimia Farmasi Tbk targets this years revenue to soar by 3.22% to IDR3.2 trillion from last years target by IDR3.1 trillion. While, its net income is predicted to grow by `5.38% to IDR90 billion from previous

JAKARTA: Indonesias pharmaceutical company, PT Kimia Farmasi Tbk targets this years revenue to soar by 3.22% to IDR3.2 trillion from last years target by IDR3.1 trillion. While, its net income is predicted to grow by `5.38% to IDR90 billion from previous years target of IDR78 billion.Corporate Secretary of Kimia Farma Adhi Nugroho informed that the target will be realized through several plans, including joint venture with Malaysias pharmaceutical distributor, Averroes Pharmaceuticals Sdn. Bhd.Then, about IDR30 billion-DIR40 billion is allocated for completing a feasibility study of Chinese-owned pharmaceutical company, Tianjian King York, as well as for acquiring 2 to 3 herbal factories in East java and Central Java, he confirmed in Jakarta, yesterday.Focusing on Averroes, the company eyes 51% shares that is still negotiated as Averroes intends to control 30% shares. At the first, the joint venture will open three drugstores in Malaysia with investment value of IDR9 billion. (t01/wiw)

Cek Berita dan Artikel yang lain di Google News dan WA Channel


Editor : Mursito

Topik

Konten Premium

Dapatkan informasi komprehensif di Bisnis.com yang diolah secara mendalam untuk menavigasi bisnis Anda. Silakan login untuk menikmati artikel Konten Premium.

Artikel Terkait

Berita Lainnya

Berita Terbaru

Nyaman tanpa iklan. Langganan BisnisPro

Nyaman tanpa iklan. Langganan BisnisPro

# Hot Topic

Nyaman tanpa iklan. Langganan BisnisPro

Rekomendasi Kami

Nyaman tanpa iklan. Langganan BisnisPro

Foto

Nyaman tanpa iklan. Langganan BisnisPro

Scan QR Code Bisnis Indonesia e-paper